Trends in stage-specific population-based survival of cancer patients in the Czech Republic in the period 2000

Trends in stage-specific population-based survival of cancer patients in the Czech Republic in the period 2000–2008

Published:2014-02 Issue:1 Volume:38 Page:28-34
ISSN:1877-7821
Container-title:Cancer Epidemiology
language:en
Short-container-title:Cancer Epidemiology

Author:

Pavlík Tomáš,Májek Ondřej,Büchler Tomáš,Vyzula Rostislav,Petera Jiří,Ryska Miroslav,Ryška Aleš,Cibula David,Babjuk Marko,Abrahámová Jitka,Vorlíček Jiří,Mužík Jan,Dušek Ladislav

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Epidemiology

Reference34 articles.

1. Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995–99: results of the EUROCARE-4 study;Berrino;Lancet Oncol,2007

2. Recent cancer survival in Europe: a 2000–02 period analysis of EUROCARE-4 data;Verdecchia;Lancet Oncol,2007

3. Cancer survival in five continents: a worldwide population-based study (CONCORD);Coleman;Lancet Oncol,2008

4. Recent major progress in long-term cancer patient survival disclosed by modeled period analysis;Brenner;J Clin Oncol,2007

5. Cancer survival in Germany and the United States at the beginning of the 21st century: an up-to-date comparison by period analysis;Gondos;Int J Cancer,2007

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of primary endoscopic resection on oncological outcomes after esophagectomy for cancer: a retrospective propensity score-based cohort study;Surgical Endoscopy;2024-07-22

2. Changes in survival in de novo metastatic cancer in an era of new medicines;JNCI: Journal of the National Cancer Institute;2023-03-29

3. Towards less mutilating treatments in patients with advanced non-melanoma skin cancers by earlier use of immune checkpoint inhibitors;Critical Reviews in Oncology/Hematology;2022-12

4. Trends of stomach cancer survival: A systematic review of survival rates from population‐based cancer registration;Journal of Digestive Diseases;2022-01

5. Anti-cancer therapy-induced metabolic syndrome;Vnitřní lékařství;2021-10-13